Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News HTG Molecular Diagnostics Inc HTGMQ

Healthcare Medical Devices
HTG Molecular Diagnostics, Inc. is a life science company. The Company is focused on advancing precision medicine and drug discovery through its transcriptome-wide profiling and advanced drug discovery platform technologies. The Company is engaged in the sales of its HTG EdgeSeq system and integrated next-generation sequencing-based (NGS-based) HTG EdgeSeq research use only (RUO) assays and... see more

Recent & Breaking News (GREY:HTGMQ)

HTG Molecular Appoints Dr. Maureen T. Cronin as Chief Scientific Officer and Senior Vice President

GlobeNewswire October 31, 2018

HTG Molecular Diagnostics to Announce Third Quarter and Nine Months Ended September 30, 2018 Financial Results and Host Conference Call on Thursday, November 8

GlobeNewswire October 25, 2018

HTG Molecular Diagnostics Announces the Institute of Oncology Research Has Adopted the HTG EdgeSeq Technology in its Genomics Facility

GlobeNewswire October 23, 2018

Recent Analysis Shows Professional Diversity Network, Quanex Building Products, HTG Molecular Diagnostics, La Jolla Pharmaceutical, Playa Hotels & Resorts N.V, and Plexus Market Influences — Renewed Outlook, Key Drivers of Growth

GlobeNewswire October 16, 2018

HTG Molecular Announces Extension to Precision Diagnostic Partnership (PDP) Program Three for Companion Diagnostic Submission

GlobeNewswire September 27, 2018

HTG Molecular to Present a Corporate Overview at the Cantor Fitzgerald Global Healthcare Conference

GlobeNewswire September 26, 2018

HTG Molecular to Present a Corporate Overview at the H.C. Wainwright 20th Annual Global Investment Conference

GlobeNewswire August 30, 2018

HTG Introduces the HTG EdgeSeq Mouse miRNA Whole Transcriptome Assay, a Comprehensive Panel for miRNA Expression Analysis for use in Translational Medicine and Preclinical Studies

GlobeNewswire August 29, 2018

HTG Molecular Announces 2nd Amendment to Second Statement of Work with QIAGEN Manchester Limited

GlobeNewswire August 20, 2018

HTG Molecular Appoints Michelle R. Griffin to its Board of Directors

GlobeNewswire August 16, 2018

HTG Molecular Diagnostics Fulfills First Orders for its Next-Generation Sequencing-Based HTG EdgeSeq Precision Immuno-Oncology Panel

GlobeNewswire August 15, 2018

HTG Molecular Announces Amendment to Second Statement of Work with QIAGEN Manchester Limited

GlobeNewswire August 9, 2018

HTG Molecular Diagnostics Reports Second Quarter 2018 Results

GlobeNewswire August 7, 2018

HTG Molecular Diagnostics and Oncologie, Inc. Complete Master Agreement to Partner on Biomarker Development for Immuno-oncology Drug Development

GlobeNewswire August 3, 2018

HTG Molecular Diagnostics to Present at Canaccord Genuity Growth Conference

GlobeNewswire August 1, 2018

HTG Molecular Diagnostics to Announce Second Quarter and Six Months Ended June 30, 2018 Financial Results and Host Conference Call on Tuesday, August 7

GlobeNewswire July 24, 2018

HTG Molecular Diagnostics Reports First Quarter 2018 Results

GlobeNewswire May 10, 2018

HTG Molecular Diagnostics to Feature Its HTG EdgeSeq Precision Immuno-Oncology Panel at Booth #4113 at the American Society of Clinical Oncology (ASCO) Conference in June 2018

GlobeNewswire May 10, 2018

HTG Molecular Diagnostics and Firalis Announce an Agreement Enabling Firalis’ Commercialization of Theranostic and Research Products and Services Based on HTG EdgeSeq Technology

GlobeNewswire May 7, 2018

HTG Promotes John Lubniewski to President and Chief Operating Officer

GlobeNewswire April 16, 2018